bioRxiv · 20 Nov 2026
Spatial organization of a SPINK1-associated tumor-stromal ecosystem links metabolic remodeling to immune restriction in bladder cancer
Qiyi Yu, Yifan Wu, Xuedan Han, Yu Lu, Huilong Li, Yi Da Douglas Jiang, Jingyi Zhou, Yan Li, Hang Huang, Wei Chen, Xiaoman Li, Fangdie Ye, Lufeng Zhengh-index 23
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Spatially organized tumor-stromal interactions contribute to metabolic remodeling and immune suppression in bladder cancer (BLCA). Using spatial transcriptional programs to define single-cell states, we identified a niche comprising SPINK1-high epithelial cells (E2) and TPM2-high cancer-associated fibroblasts (CAFs) (C1). SPINK1 promoted tumor growth and myofibroblastic CAF programs, with EGFR and TGF-{beta} signaling implicated in tumor-CAF communication. Inferred metabolic reactions and spatial metabolite distributions supported a candidate circuit linking tumor-derived lactate to CAF oxidative metabolism and glutamine provision, followed by tumor glutamine utilization for reductive carboxylation and fatty acid synthesis. SPINK1 perturbation altered extracellular glutamine and lactate concentrations. Predicted chemokine interactions implicated C2/C3 CAFs in T cell recruitment, whereas the E2-C1 niche exhibited checkpoint and exhaustion-associated features. RHCG-positive tumor regions contained higher proportions of TOXCXCR4 cells among CD3 T cells, suggesting a possible association between ammonia handling and T cell dysfunction. In vivo, Spink1 loss attenuated tumor progression, increased cytotoxic CD8 T-cell infiltration, and enhanced tumor control during PD-1 blockade. These findings identify a spatially organized tumor-stromal niche associated with metabolic cooperation and immune restriction, supporting SPINK1 as a candidate therapeutic target in combination with immunotherapy.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Lufeng Zheng has the highest h-index among the authors (23).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.